Going beyond genomics to a healthier future
Genomic medicine is here to stay – but more needs to be done to ensure NHS patients can benefit, was the message coming loud and clear at the conference held by Cambridge health policy think tank, the PHG Foundation, this week. Learning from the genomics experience will be crucial as new technologies come on stream to transform and personalise healthcare delivery, delegates were advised.
'Data and context are key for robust AI in healthcare'
Giving evidence on Artificial Intelligence to a House of Lords Select Committee, PHG Foundation's Dr Sobia Raza highlighted the need for an NHS-wide strategy on using health data for algorithm development to realise the benefits of AI for patients.
PHG Foundation announces new Director
We are pleased to announce Dr Mark Kroese as the new Director of the PHG Foundation. Mark will be taking over from Dr Hilary Burton, who stepped down as Director at the end of September.
Report calls for increased awareness of ctDNA testing for lung cancer
A report published by the PHG Foundation argues that limited awareness of validated ctDNA testing technology is restricting access to targeted therapy in a sub-group of patients with non-small cell lung cancer.
Cambridge genomics pioneers celebrate 20 years of making science work for health
With the Chief Medical Officer's 2017 annual report focusing on genomics, local genomics pioneers, PHG Foundation had plenty to celebrate at their 20th anniversary gala dinner this week.
NHS discount for conference on the future of personalised healthcare
Personalised healthcare and genomic medicine will be in the spotlight at a Cambridge conference this autumn. Examining the implications of genomics and other technologies on the delivery of healthcare, ‘Healthy futures: genomics and beyond’ on 28 November 2017 is a must for those working at the frontline of healthcare.
Chief Scientific Officer speaks at Cambridge conference
The Chief Scientific Officer, Professor Sue Hill, will speak at a forthcoming Cambridge conference on the future of health provision.
Success of future health systems hinges on access to data, say experts
An international group of population health experts is calling for sharing of health data to be the norm if precision health agendas are to succeed and build sustainable health systems.
Personalised healthcare: making the most of genomics
A day of expert insight, multidisciplinary discussion and informal networking on personalised healthcare and policy will take place on 29 November at Robinson College, Cambridge.
PHG Foundation at the Precision Medicine Forum London 2016
PHG Foundation Director, Dr Hilary Burton will be at the Precision Medicine Forum London 2016 next month to share her insights on mainstreaming genomics in the NHS.
The measured man: the next frontier in medical research?
Is the time right for a move from genetic testing and biobanking at specific time-points to continuous, real-time monitoring of individuals? This is the subject of a free seminar in Cambridge on Thursday 7 July 2016 by Professor Bartha Knoppers, Director, Centre of Genomics and Policy, McGill University.
Data integration is key to personalised medicine in the NHS
UK Life Sciences Minister George Freeman MP this week said that the UK National Health Service (NHS) needed to become much better at integrating health and disease data sets in order to realise the full potential of personalised medicine for patient benefit.
New Parliamentary Group sets out to explore promise of personalised medicine
The Cambridge biotech cluster is playing a significant role in establishing a new All-Party Parliamentary Group (APPG) on Personalised Medicine. It aims to help the NHS and patients make best use of cutting-edge technologies to provide more personalised health and care.
Regulation of medical research under European Data Protection
European Parliament, Commission and Council is currently debating changes to General Data Protection Regulation. But what do changes in European data protection mean for health and scientific research across the EU?
Selling science? News, public relations and communicating scientific research
In the era of 140 character tweets and 500 word blogs, how can the scientific community successfully yet accurately engage journalists with the results of its research?
Regulating new health technologies: the 'three-person IVF' story
Have you ever wondered how regulatory decisions are made about controversial new health technologies?
Events focus on personal data and personalised medicine
A new era of personalised medicine is becoming a reality with the 100,000 Genomes Project in the UK and US President Obama last month announcing his precision medicine initiative. As personalised medicine comes into focus, so does the accompanying debate over the challenges and potential of big data.
Big data: Privacy, public interest and the future of healthcare research
Interest in the potential and pitfalls of big data shows little sign of abating, especially here in Cambridge if the packed auditorium for the recent launch of the PHG Foundation’s Life Sciences & Society seminar series is anything to go by.
Bioscience and innovation for health - examining the issues
A new series of lively seminars taking a broad perspective on bioscience, health and the policy implications of innovation in the UK health system launches in Cambridge next month.
PHG toolkit in Brazil 2014 transfer deal
PHG Foundation director, Hilary Burton, was in Brazil last week to officially hand over ownership of the PHG Foundation-developed Health Needs Assessment Toolkit for Congenital Disorders, to a consortium from a national centre of excellence in genetics and congenital disorders based in Porto Alegre.
PHG Foundation joins new global pact on responsible use of genomics for health
A new global alliance is setting out to ensure that the benefits of genomics sequencing for health are realised as promptly and efficiently as possible - whilst protecting patients and research participants.
Personalised cancer screening to include genetic testing
Future cancer screening may be improved by the use of genetic information, predicts new research led by the PHG Foundation and the University of Cambridge; but greater accuracy will come at the price of increased complexity.
Genomic knowledge and the future for cancer screening
Cambridge-based PHG Foundation, as part of a European-wide collaboration, has been investigating how information from a range of sources, including our genes, may help an individual to decide whether screening is right for her or him.
Making science work for health: Translating Genomics 2012
The road of the genomic ‘revolution’ has perhaps been more winding path than superhighway. Nevertheless, the role genomics has to play in the future health of populations is becoming rapidly clearer.
A global roadmap to tackling birth defects at the local level
A pioneering resource to help tackle birth defects, particularly in low and middle income countries (LMICs), is now available free and online to health and policy professionals and patient groups across the globe. The PHG Foundation Health Needs Assessment Toolkit for Congenital Disorders (also known as birth defects), is a comprehensive database, information resource and roadmap to creating…